Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Kim, Jennifer H
While all GLP-1 drugs influence appetite and metabolism, only some (like semaglutide and tirzepatide) are FDA-approved specifically for weight management
At Inspira, we work closely with pharmaceutical reps to get the latest indications for these medications
So far, semaglutide (Wegovy) shows the most significant weight loss among approved GLP-1s: Average weight loss: 15 percent or more of body weight over time Administered once weekly Tirzepatide (Mounjaro), though not a pure GLP-1, has shown even greater weight loss in trials and was approved by the FDA specifically for weight management under the name Zepbound
In addition, drug interactions may occur with: Insulin or sulfonylureas (increased risk of hypoglycemia) Other medications slowed by delayed gastric emptying Always consult with a healthcare provider before starting any new medication
US$ 28.04
US$ 25.85
US$ 28.16
US$ 24.96
US$ 25.74
US$ 24.44
US$ 23.36
